Application

15692116 · RECEPTOR-TARGETED NANOPARTICLES FOR ENHANCED TRANSCYTOSIS MEDIATED DRUG DELIVERY

Filed 2017-08-31 · Abandoned The official file ↗ · Art unit 1611 · Examiner Kyle A Purdy Typical · CPC A61K 47/6931 · Massachusetts Institute of Technology · PABST PATENT GROUP LLP

Office actions

first was Restriction requirement

RCEs

appealed

To first action

9.7 mo

to disposition 48.5 mo

Statutes raised

103 112

5 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.